2024 first quarter consolidated interim report (unaudited)
May 09, 2024 01:00 ET
|
Nordecon
The first quarter of 2024 of the Nordecon Group is characterized by an increase in sales revenue, an improvement in profitability and an increase in the order book.The sales revenue of the first...
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease
May 01, 2024 06:55 ET
|
Janssen Cilag International NV
Media contact:Sophie DaneauSdaneau@its.jnj.com+33 6 3178 8798Investor contact:Raychel Kruperinvestor-relations@its.jnj.com For European and UK medical and trade media only For immediate...
Johnson & Johnson receives positive CHMP opinion for RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations
April 26, 2024 07:55 ET
|
Janssen Cilag International NV
This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of EGFR exon 20 insertion-mutated NSCLC ...
Orion Group Interim Report January–March 2024
April 25, 2024 05:00 ET
|
Orion Oyj
ORION CORPORATION INTERIM REPORT 1-3/2024 25 APRIL 2024 at 12:00 EEST Orion Group Interim Report January–March 2024 Net sales totalled EUR 308.5...
CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy
April 22, 2024 06:41 ET
|
Janssen Cilag International NV
Expanded indication for this one-time infusion may provide patients with a potential period away from their multiple myeloma treatment as early as first relapse1 Approval is based on results...
Global Additive Manufacturing Market Size To Worth USD 143.3 Billion By 2033 | CAGR Of 21.78%
April 19, 2024 04:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 19, 2024 (GLOBE NEWSWIRE) -- The Global Additive Manufacturing Market Size is to Grow from USD 19.97 Billion in 2023 to USD 143.3 Billion by 2033, at a Compound...
3D Printing Services Procurement Market Soars to $19 Billion in 2022, Expected 20-25% CAGR by 2026 | ELINT Market Research
April 15, 2024 13:54 ET
|
ELINT Market Research
Albuquerque, April 15, 2024 (GLOBE NEWSWIRE) -- According to ELINT Market Research’s recent report, the worldwide 3D Printing Services Market achieved a $19 billion value in the year 2022 and will...
OneSavingsBank plc - 2023 Annual Report and Accounts
April 10, 2024 02:45 ET
|
OSB GROUP PLC
LEI: 213800WTQKOQI8ELD692 OneSavings Bank plc - 2023 Annual Report and Accounts In fulfilment of its obligations under section 4.1.3 and 6.3.5(1) of the Disclosure Guidance and Transparency...
WINFARM : 2023 Full-Year Results and outlook for 2024.
March 28, 2024 13:00 ET
|
Winfarm
PRESS RELEASE Loudéac, 28 March 2024 2023 FULL-YEAR RESULTS Revenue up 5% despite the widespread fall in prices Sharp fall in activity in the fourth quarter, which weighed on EBITDA OUTLOOK FOR...
OXURION announces its presence at the Paris SmallCap event on March 28, 2024.
March 25, 2024 14:10 ET
|
Oxurion NV
OXURION announces its presence at the Paris SmallCapevent on March 28, 2024. Leuven, BELGIUM - March 25, 2024 - 7:00 p.m, Oxurion NV (Euronext Brussels : OXUR), a Leuven-based biopharmaceutical...